(Q26824810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

review article

4 references

23 November 2020

1 February 2021

28 October 2022

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events (English)

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

idiopathic pulmonary fibrosis

10 March 2020

main subject

idiopathy

0 references

tumor necrosis factor

2 references

1 August 2019

1 February 2021

4 references

1 August 2019

17 September 2019

20 November 2019

27 November 2019

heterocyclic compound

1 reference

17 September 2019

1 reference

20 November 2019

1 reference

27 November 2019

1 reference

adverse drug reaction

1 reference

23 November 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Toby Maher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

María Molina-Molina

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Carlo Vancheri

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

Ulrich Costabel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

3

Vincent Cottin

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

9

Michael Kreuter

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Elisabeth Bendstrup

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Pieter Dewint

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

James Ferguson

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Richard Groves

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Klas Nordlind

12

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Alexandre Sarafidis

13

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jim J J Egan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

1 reference

18 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 April 2014

3 references

23 November 2020

1 February 2021

28 October 2022

9 references

1 August 2019

17 September 2019

20 November 2019

27 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

23 November 2020

1 February 2021

28 October 2022

31

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

4

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

375-391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

Idiopathic pulmonary fibrosis

10 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Classification and natural history of the idiopathic interstitial pneumonias

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Antifibrotic activities of pirfenidone in animal models

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

The rising incidence of idiopathic pulmonary fibrosis in the U.K

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Pirfenidone in idiopathic pulmonary fibrosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Real world experiences: pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Clinical course and prediction of survival in idiopathic pulmonary fibrosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Pirfenidone: an anti-fibrotic therapy for progressive kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Acute exacerbations of idiopathic pulmonary fibrosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Comparison of registries of interstitial lung diseases in three European countries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003341

Epidemiology of interstitial lung diseases in Greece

28 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0112-1

Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0112-1

Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0112-1

Photosafety assessments on pirfenidone: photochemical, photobiological, and pharmacokinetic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0112-1

10.1007/S12325-014-0112-1

21 January 2018

Identifiers

DOI

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 March 2020

1051038083

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

PubMed publication ID

24639005

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24639005%20AND%20SRC:MED&resulttype=core&format=json